1. Home
  2. ENTX vs CHMI Comparison

ENTX vs CHMI Comparison

Compare ENTX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • CHMI
  • Stock Information
  • Founded
  • ENTX 2010
  • CHMI 2012
  • Country
  • ENTX Israel
  • CHMI United States
  • Employees
  • ENTX N/A
  • CHMI N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CHMI Real Estate Investment Trusts
  • Sector
  • ENTX Health Care
  • CHMI Real Estate
  • Exchange
  • ENTX Nasdaq
  • CHMI Nasdaq
  • Market Cap
  • ENTX 90.2M
  • CHMI 92.0M
  • IPO Year
  • ENTX 2018
  • CHMI 2013
  • Fundamental
  • Price
  • ENTX $2.38
  • CHMI $3.44
  • Analyst Decision
  • ENTX Strong Buy
  • CHMI Buy
  • Analyst Count
  • ENTX 1
  • CHMI 3
  • Target Price
  • ENTX $10.00
  • CHMI $5.00
  • AVG Volume (30 Days)
  • ENTX 93.1K
  • CHMI 257.7K
  • Earning Date
  • ENTX 03-07-2025
  • CHMI 03-06-2025
  • Dividend Yield
  • ENTX N/A
  • CHMI 17.49%
  • EPS Growth
  • ENTX N/A
  • CHMI N/A
  • EPS
  • ENTX N/A
  • CHMI N/A
  • Revenue
  • ENTX $99,000.00
  • CHMI N/A
  • Revenue This Year
  • ENTX N/A
  • CHMI N/A
  • Revenue Next Year
  • ENTX N/A
  • CHMI $27.78
  • P/E Ratio
  • ENTX N/A
  • CHMI N/A
  • Revenue Growth
  • ENTX 607.14
  • CHMI N/A
  • 52 Week Low
  • ENTX $0.82
  • CHMI $2.50
  • 52 Week High
  • ENTX $3.35
  • CHMI $3.99
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 52.12
  • CHMI 71.02
  • Support Level
  • ENTX $2.32
  • CHMI $3.31
  • Resistance Level
  • ENTX $2.62
  • CHMI $3.52
  • Average True Range (ATR)
  • ENTX 0.21
  • CHMI 0.10
  • MACD
  • ENTX -0.00
  • CHMI 0.01
  • Stochastic Oscillator
  • ENTX 61.29
  • CHMI 83.67

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: